Sunday, December 14, 2014
Lack of information vs. marketing is suspicious
Read with your brain engaged
© Madelyn Griffith-Haynie, CTP, CMC, ACT, MCC, SCAC
from the Non-Pharm Alternatives Series
Preliminary findings: short and not so sweet
For those of us with Executive Functioning Dysregulation issues [EFD], a new product on the performance enhancement market touted as the Viagra for the Brain sounds like a nootropic answer to a prayer.
You may have heard about it as EVO, “the Limitless Pill” (E-Huperzine) – credited as the genesis of the idea for the film. The buzz about Neuroflexyn increased rapidly after Limitless became a Box Office smash hit and publicly referenced Neuroflexyn as its inspiration.
Here’s what the folks at smartSMARTER have to say about the product in their introduction to a clearly marked ADVERTISEMENT (designed nonetheless to look like something else):
We expose the truth behind a ground-breaking pill that has many experts furious. Studies have revealed it boosts brain power by up to 89.2%, sharpens your mind and sky-rockets your energy levels. With such overwhelming evidence and media mention, the question is not whether the pill works, but whether it should be legal.
Too good to be true?
A plethora of marketing-posing-as-information articles make some pretty amazing claims about the benefits of Neuroflexyn. I’ll admit that I was tempted to purchase as I read them – which is what launched me on the informational research trail.
Product marketing swears that Neuroflexyn has been “proven” to significantly increase IQ as it enhances memory, concentration, intentional focus — productivity practically across the board, in fact.
In addition, again according to their marketing, this new “supplement” dramatically increases cognition and intelligence with NO reported side effects.
Ahem! As you may already be aware, the FDA does not currently regulate supplements. Whether or not that is ultimately a good thing or turns out to be a lousy way to attempt to protect the public, it does mean that this new product currently flies beneath FDA radar.
The manufacturer can pretty much claim anything they want
in their attempt to sell their product.
It is up to us to determine how ethical they appear to be, in contrast to any eagerness to part us from our wallets by any means available, in service of corporate profitability.
Not to seem to have joined some Royal Society of Skeptics, my Boomer lifetime of experience has taught me that whenever something sounds too good to be true, it usually is (not true, that is).
NEXT year’s stocking stuffer, maybe
Before any of YOU put any of your hard-earned Christmas cash into a product trial – as a gift or for yourself – take a few moments to read what I have to say about why you might want to wait until more results are in.
In addition to other reasons I’m skeptical, I always advise caution any time product marketing attempts to manipulate us into buying — rather than enticing us into that action with information designed to help us to come to a decision.
I DO NOT Heart Scare Tactics
It seems to be a popular “ask for the sale” approach to attempt to sweeten response rate with text urging readers to take hasty action for fear of losing some advantage or opportunity if they take a day or more to think things over or investigate other options.
Neuroflexyn’s marketing game-plan seems to be to set up “Big Pharma” as the bogey-man, supposedly intent on shutting down Neuroflexyn production because it is “competition” for the profitability of their pharmaceutical products.
Uh-huh – so buy now or regret it when
Neuroflexyn is taken off the market?
I guess that implies that one must seriously stock up from the very beginning – just in case it really does work – to ensure access to a continued supply during the upcoming fight for manufacturing rights. Let’s all go get right on it, then!
Read more of this post